Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Vaginal Specula

Active
MW-2105-25Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract modification announces the release of the Qualified Suppliers List (QSL) for the procurement of disposable vaginal specula with a light source, designated under solicitation number MW-2105-25. The Department of Defense’s Defense Logistics Agency (DLA) Troop Support office, based in Philadelphia, Pennsylvania, is managing this presolicitation. The intended place of performance for the contract is Frederick, Maryland. The announcement serves to notify qualified entities interested in providing these medical devices that the full solicitation and related information are available electronically through the System for Award Management (SAM) website. The solicitation falls under the NAICS code 339113, which pertains to surgical and medical instrument manufacturing. The contract points of contact include the MMESO Enterprise Wide Standardization team and Tara J. Perrien, the Contracting Officer. Interested vendors are encouraged to access all relevant documents and updates via the SAM portal to participate in this opportunity to supply the specified disposable vaginal specula with light source, which will support military medical requirements.

General Info

DLA Troop Support seeks qualified suppliers for disposable vaginal specula with light, solicitation MW-2105-25.

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhasePresolicitation
Posted

Presolicitation

Notice updated

The notice description changed.

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA
Contacts
MMESO Enterprise Wide Standardization
Tara J. Perrien Contracting Officer

Full Description

Show more
The purpose of this modification to the Notice of Intent (NOI)/Presolicitation to establish a QSL is to inform qualified entities interested in providing these services that the release of the QSL Announcement for MW-2108-43 Vaginal Specula Disposable with Light Source, has been issued. All solicitation information is available electronically on the System for Award Management (SAM) website.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

NAICS: 326199
New
Federal
Synopsis for Outserts (NSN - 4240-01-529-8327 & 4240-01-528-9288)
Solicitation # 015298327_015289288
Solicitation SPE8EG-26-R-0003 is an unrestricted, fixed-price with economic price adjustment, indefinite delivery/indefinite quantity contract issued by DLA Troop Support for the procurement of critical Chemical Biological Radiation and Nuclear Personal Protective Equipment. The requirement consists of two National Stock Numbers: Clear Assembly Outserts (NSN 4240-01-529-8327) and Laser Assembly Outserts (NSN 4240-01-528-9288). The contract structure includes a one-year base period with four one-year option periods. Delivery terms are FOB Origin, with inspection and acceptance also occurring at origin. Price is the sole evaluated factor for award. Avon Protection Systems Incorporated is the approved source for these items. Due to the critical nature of the application, only approved part numbers are authorized unless a complete data package for an alternate is provided for evaluation. The procurement is subject to strict export controls under ITAR and EAR, requiring offerors to have an approved US/Canada Joint Certification Program certification and DLA authorization to access technical data. Additionally, while Cybersecurity Maturity Model Certification Level 2 requirements apply to these materials, they are not required for the initial award but will be necessary for future continued performance. The solicitation closing date has been extended multiple times and is currently set for November 13, 2026, at 3:00 PM EDT.
All Other Plastics Product Manufacturing

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 325412
New
Federal
Atropine Auto-Injector
Solicitation # SPE2DP-27-R-ATRO
DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS